'I have no objection to the parade. But can organisers reduce the noise?
READ MOREShahzada Dawood and his son Suleman were killed in the disaster (Picture: AFP/GETTY IMAGES) A grieving mother said her husband and son killed in the Titan sub disaster,were given back to her as ‘s
The officials were 'supporting Chihuahua state authorities’ efforts to combat cartel operations.
SYDNEY,March 12,2025-- Meizu,in collaboration with Geely Autoheld a product launch event in Sydney,Australia,unveiling several smartphones tailored for overseas markets and various tech innovations in
SHANGRAO,China,March 12,2025-- JinkoSolar Holding Co.,Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS),one of the largest and most innovative solar module manufacturers in the worl
GUANGZHOU,China,March 12,2025-- ZWSOFT proudly announces that its flagship products,ZWCAD and ZW3D,have been named to G2\'s 2025 Best Software Awards,ranking among the top 50 in the CAD & PLM cate
SOUTHFIELD,Mich.,March 12,2025-- Lear Corporation (NYSE: LEA),a global automotive technology leader in Seating and E-Systems,recently announced a key engineering integration with General Motors,begin
SHANGHAI,March 12,2025-- 111,Inc. ("111" or the "Company") (NASDAQ: YI),a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare indu
WASHINGTON,March 13,2025-- Shield AI is issuing a correction to its previously released announcement,"Shield AI raises $240M at $5.3B valuation to scaleHivemind Enterprise,an AI-powered autonomy
New automation solutions and material advancements aim to streamline workflows and expand possibilities for dental labs
SHENZHEN,China,March 13,2025-- Casual,a leading global video production company known for award-winning content and storytelling,proudly announces theopening of its first Mainland China office,凯视,in
PITTSBURGH,March 13,2025-- Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 revolution. These innov
STEQEYMA®,one of the first-wave biosimilars to STELARA®,is now available in the U.S. Approved for the same indications as the reference product,STEQEYMA will be priced with a wholesale acquis
© OfficialAffairs
